AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35352703 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy intervention teaching pain self-management skills in 12 weekly, 90-minute groups
Number of subjects: 814
Study 35352703 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 814
Study 35352703 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy intervention
Number of subjects: 814
Study 33972581 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric-acid dialysate (C1.5) with dCa of 1.50 mmol/l
Number of subjects: 13
Study 33972581 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetic-acid dialysate with dCa of 1.25 mmol/l (A1.25)
Number of subjects: 13
Study 33972581 — intervention group
Group type: COMPARATOR
Intervention: Acetic-acid dialysate with dCa of 1.50 mmol/l (A1.5)
Number of subjects: 13
Study 32604162 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX (FFX)
Number of subjects: 413
Study 32604162 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine plus nab-paclitaxel (GNP)
Number of subjects: 413
Study 32604162 — intervention group
Group type: EXPERIMENTAL
Intervention: FFX-GNP
Number of subjects: 413
Study 32604162 — intervention group
Group type: COMPARATOR
Intervention: GNP-FFX
Number of subjects: 413
Study 35411183 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 88
Study 35411183 — intervention group
Group type: COMPARATOR
Intervention: Medication
Number of subjects: 88
Study 33417730 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg once daily for 5 consecutive days
Number of subjects: 0
Study 33417730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33417730 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 0
Study 36293971 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g/kg body weight)
Number of subjects: 10
Study 36293971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 34388379 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (VEGF inhibitor) added to Erlotinib (EGFR inhibitor)
Number of subjects: 0
Study 34388379 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib (EGFR inhibitor) alone
Number of subjects: 0
Study 35167361 — intervention group
Group type: COMPARATOR
Intervention: Online Yoga (OY) only
Number of subjects: 60
Study 35167361 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Yoga with Facebook (OYFB)
Number of subjects: 60
Study 35167361 — intervention group
Group type: COMPARATOR
Intervention: Both groups (OY and OYFB)
Number of subjects: 60
Study 34208829 — intervention group
Group type: EXPERIMENTAL
Intervention: SCD acute plasma samples
Number of subjects: 54
Study 34208829 — intervention group
Group type: EXPERIMENTAL
Intervention: SCD steady-state plasma samples
Number of subjects: 54
Study 34208829 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical agents acting on RBC membrane channels
Number of subjects: 54
Study 34208829 — intervention group
Group type: COMPARATOR
Intervention: Recombinant Annexin V pre-treatment
Number of subjects: 54
Study 34208829 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulators of RBC membrane channels (activating Piezo1 Ca2+ channel)
Number of subjects: 54
Study 34208829 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocking Ca2+-dependent K+ Gardos channel
Number of subjects: 54
Study 32369761 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week proprioceptive training, 5 times per week for 10 minutes
Number of subjects: 16
Study 32369761 — intervention group
Group type: COMPARATOR
Intervention: Nontraining group
Number of subjects: 16
Study 35051662 — intervention group
Group type: EXPERIMENTAL
Intervention: Connect through PLAY intervention
Number of subjects: 30
Study 35051662 — intervention group
Group type: COMPARATOR
Intervention: Active health curriculum control
Number of subjects: 30
Study 34810363 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Number of subjects: 160
Study 34810363 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy
Number of subjects: 160
Study 34810363 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with education for self‐management and counseling
Number of subjects: 160
Study 34810363 — intervention group
Group type: COMPARATOR
Intervention: Education for self‐management and counseling (Control)
Number of subjects: 160
Study 35483981 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative stroke
Number of subjects: 383
Study 35483981 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium
Number of subjects: 383
Study 32879932 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mm abutment with thin mucosa
Number of subjects: 80
Study 32879932 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mm abutment with thick mucosa
Number of subjects: 80
Study 32879932 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mm abutment with thin mucosa
Number of subjects: 80
Study 32879932 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mm abutment with thick mucosa
Number of subjects: 80
Study 32879932 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mm abutment
Number of subjects: 80
Study 32879932 — intervention group
Group type: COMPARATOR
Intervention: 3 mm abutment
Number of subjects: 80
Study 34748133 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational video about autism
Number of subjects: 152
Study 34748133 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 152
Study 33966335 — intervention group
Group type: EXPERIMENTAL
Intervention: TTNS once a week for 30 minutes for 12 weeks
Number of subjects: 60
Study 33966335 — intervention group
Group type: COMPARATOR
Intervention: TTNS three times a week for 30 minutes for 12 weeks
Number of subjects: 60
Study 33109641 — intervention group
Group type: EXPERIMENTAL
Intervention: IA injection of HA+CS combined with duloxetine
Number of subjects: 150
Study 33109641 — intervention group
Group type: COMPARATOR
Intervention: IA injection of HA+CS alone
Number of subjects: 150
Study 35030257 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 259
Study 35030257 — intervention group
Group type: COMPARATOR
Intervention: Escalated antiarrhythmic drug therapy
Number of subjects: 259
Study 35030257 — intervention group
Group type: COMPARATOR
Intervention: Escalated antiarrhythmic drug therapy (specifically amiodarone)
Number of subjects: 259
Study 34160595 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus psychosocial treatment
Number of subjects: 59
Study 34160595 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medication plus psychosocial treatment
Number of subjects: 59
Study 34160595 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 59
Study 35058236 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg CC-90001
Number of subjects: 210
Study 35058236 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg CC-90001
Number of subjects: 210
Study 35058236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 35058236 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg CC-90001 (PF-ILD substudy)
Number of subjects: 210
Study 35058236 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PF-ILD substudy)
Number of subjects: 210
Study 34854347 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based plus positive psychological training (PPT)
Number of subjects: 18
Study 34854347 — intervention group
Group type: COMPARATOR
Intervention: Technology-based intervention alone (comparison group)
Number of subjects: 18
Study 35822730 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (8 mm Hg) with deep neuromuscular blockade (posttetanic count 1-2)
Number of subjects: 178
Study 35822730 — intervention group
Group type: COMPARATOR
Intervention: Standard-pressure pneumoperitoneum (12 mm Hg) with moderate neuromuscular blockade (train-of-four 1-2)
Number of subjects: 178
Study 36357967 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (approach to reduce sedentary behaviour)
Number of subjects: 86
Study 36357967 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care during hospitalisation)
Number of subjects: 86
Study 33565826 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient blood management strategies implemented (207 patients)
Number of subjects: 409
Study 33565826 — intervention group
Group type: COMPARATOR
Intervention: No patient blood management strategies (202 patients)
Number of subjects: 409
Study 33045374 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% daily contrast increment protocol
Number of subjects: 63
Study 33045374 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% daily contrast increment protocol
Number of subjects: 63
Study 33045374 — intervention group
Group type: EXPERIMENTAL
Intervention: 0% daily contrast increment protocol
Number of subjects: 63
Study 33045374 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% for first 4 weeks then reset to 20% and repeat 10% increment for the final 4 weeks
Number of subjects: 63
Study 33045374 — intervention group
Group type: COMPARATOR
Intervention: All protocols (10%, 5%, 0%, and 10% reset)
Number of subjects: 63
Study 35988922 — intervention group
Group type: EXPERIMENTAL
Intervention: External-country causal attribution
Number of subjects: 593
Study 35988922 — intervention group
Group type: COMPARATOR
Intervention: Internal-country causal attribution
Number of subjects: 593
Study 33744191 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based exercise rehabilitation (GE)
Number of subjects: 208
Study 33744191 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual exercise rehabilitation (IE)
Number of subjects: 208
Study 33744191 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise rehabilitation (HE)
Number of subjects: 208
Study 33744191 — intervention group
Group type: COMPARATOR
Intervention: EQ-5D-5L index
Number of subjects: 208
Study 33744191 — intervention group
Group type: COMPARATOR
Intervention: Healthcare and productivity costs
Number of subjects: 208
Study 32803888 — intervention group
Group type: EXPERIMENTAL
Intervention: Lindera strychnifolia root extract (LsR) treatment for 83 days
Number of subjects: 24
Study 32803888 — intervention group
Group type: COMPARATOR
Intervention: Control group (AGA subjects without treatment)
Number of subjects: 24
Study 35981315 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative intervention group (reading two tailored narrative messages about HPV/HPV vaccination)
Number of subjects: 101
Study 35981315 — intervention group
Group type: COMPARATOR
Intervention: Control group (reading standard Center for Disease Control information)
Number of subjects: 101
Study 33947293 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 684
Study 33947293 — intervention group
Group type: EXPERIMENTAL
Intervention: Allied staff
Number of subjects: 684
Study 33947293 — intervention group
Group type: COMPARATOR
Intervention: Care assistants
Number of subjects: 684
Study 32384095 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing with soap at critical times (doers)
Number of subjects: 90
Study 32384095 — intervention group
Group type: COMPARATOR
Intervention: Non-doers (those who do not wash their hands with soap at critical times)
Number of subjects: 90
Study 32384095 — intervention group
Group type: COMPARATOR
Intervention: Non-doers in the second camp
Number of subjects: 90
Study 36081953 — intervention group
Group type: EXPERIMENTAL
Intervention: QL1209 420 mg intravenously
Number of subjects: 137
Study 36081953 — intervention group
Group type: COMPARATOR
Intervention: Perjeta® 420 mg intravenously
Number of subjects: 137
Study 33461151 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-minute sub-maximal fitness test on a cycle ergometer
Number of subjects: 140
Study 34169539 — intervention group
Group type: EXPERIMENTAL
Intervention: LHA intervention (n=23) - four-chapter one-on-one lesson plan over 4 weeks
Number of subjects: 51
Study 34169539 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=28) - received only a health brochure
Number of subjects: 51
Study 34169539 — intervention group
Group type: EXPERIMENTAL
Intervention: LHA intervention (n=23)
Number of subjects: 51
Study 34086616 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-party health websites
Number of subjects: 0
Study 34086616 — intervention group
Group type: COMPARATOR
Intervention: Academic and nonacademic orthopaedic surgeons
Number of subjects: 0
Study 34086616 — intervention group
Group type: COMPARATOR
Intervention: Male and female providers
Number of subjects: 0
Study 34086616 — intervention group
Group type: COMPARATOR
Intervention: Surgeons from different graduation years
Number of subjects: 0
Study 36163060 — intervention group
Group type: EXPERIMENTAL
Intervention: New incision made regardless of the previous scar location (intervention group)
Number of subjects: 50
Study 36163060 — intervention group
Group type: COMPARATOR
Intervention: New incision made at least 8 cm distant from the old incision (control group)
Number of subjects: 50
Study 36163060 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Society Score (KSS) at 6 months (intervention group)
Number of subjects: 50
Study 36163060 — intervention group
Group type: COMPARATOR
Intervention: Knee Society Score (KSS) at 6 months (control group)
Number of subjects: 50
Study 34228875 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mg oral solution oxycodone
Number of subjects: 20
Study 34228875 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-mg controlled-release (water-swellable or lipid-based) oxycodone
Number of subjects: 20
Study 32092187 — intervention group
Group type: EXPERIMENTAL
Intervention: LCP‐tac and everolimus once daily
Number of subjects: 40
Study 32092187 — intervention group
Group type: COMPARATOR
Intervention: LCP‐tac and mycophenolate BID (control arm)
Number of subjects: 40
Study 35835346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ward-based goal-directed fluid therapy (GDFT)
Number of subjects: 50
Study 35835346 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 50
Study 34520293 — intervention group
Group type: EXPERIMENTAL
Intervention: CauchyCP test
Number of subjects: 0
Study 34520293 — intervention group
Group type: COMPARATOR
Intervention: Existing treatment comparison tests under non-proportional hazards
Number of subjects: 0
Study 35638455 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% NaCl solution
Number of subjects: 100
Study 35638455 — intervention group
Group type: COMPARATOR
Intervention: 30% NaCl solution
Number of subjects: 100
Study 35638455 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental satisfaction
Number of subjects: 100
Study 34218702 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-channel NMES
Number of subjects: 52
Study 34218702 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 52
Study 32521556 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-Generated Enhanced Electronic Note System (VGEENS)
Number of subjects: 31
Study 32521556 — intervention group
Group type: COMPARATOR
Intervention: Keyboard with template (control)
Number of subjects: 31
Study 36088270 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen (10mg/kg/6h)
Number of subjects: 66
Study 36088270 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ketorolac (0.5mg/kg/6h)
Number of subjects: 66
Study 36088270 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen
Number of subjects: 66
Study 32147962 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfers and monthly group nutrition education sessions led by community health volunteers
Number of subjects: 1945
Study 34732201 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 344
Study 34732201 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 344
Study 33836388 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketamine cream 10%
Number of subjects: 300
Study 33836388 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% EMLA cream
Number of subjects: 300
Study 33836388 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 g of cold cream)
Number of subjects: 300
Study 32143653 — intervention group
Group type: COMPARATOR
Intervention: Baseline altitude
Number of subjects: 20
Study 32143653 — intervention group
Group type: EXPERIMENTAL
Intervention: High altitude (3454 m above sea level)
Number of subjects: 20
Study 36469647 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 80
Study 36469647 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 80
Study 33508845 — intervention group
Group type: EXPERIMENTAL
Intervention: Predialytic oral nutritional supplements (ONS) (450 kcal energy, 20 g protein) administered 1 hour prior to dialysis
Number of subjects: 72
Study 33508845 — intervention group
Group type: COMPARATOR
Intervention: Intradialytic oral nutritional supplements (ONS) (450 kcal energy, 20 g protein) administered after 2 hours of dialysis
Number of subjects: 72
Study 32604256 — intervention group
Group type: EXPERIMENTAL
Intervention: Active in-home portable air cleaners (PACs) with HEPA filter
Number of subjects: 20
Study 32604256 — intervention group
Group type: COMPARATOR
Intervention: Sham in-home portable air cleaners (PACs)
Number of subjects: 20
Study 33768702 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine and chlorpromazine as add-on to lithium
Number of subjects: 71
Study 33768702 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 71
Study 32059039 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke identification algorithm using claims data
Number of subjects: 40443
Study 33565209 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study 33565209 — intervention group
Group type: COMPARATOR
Intervention: GLP-1 RA
Number of subjects: 0
Study 32003257 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Number Identification Test (CNIT)
Number of subjects: 10
Study 35172685 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin plus chemotherapy (A + CHP)
Number of subjects: 0
Study 33602431 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access crossover
Number of subjects: 8404
Study 33602431 — intervention group
Group type: COMPARATOR
Intervention: Successful radial access
Number of subjects: 8404
Study 33602431 — intervention group
Group type: COMPARATOR
Intervention: Successful femoral access
Number of subjects: 8404
Study 33602431 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral access crossover
Number of subjects: 8404
Study 35661358 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% bovine‐derived xenograft granules in a 10% porcine collagen matrix (Group A)
Number of subjects: 54
Study 35661358 — intervention group
Group type: COMPARATOR
Intervention: 80% microparticulate hydroxyapatite alloplast graft with 20% sugar cross‐linked porcine type 1 collagen (Group B)
Number of subjects: 54
Study 35751090 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium (group TI; N=20)
Number of subjects: 60
Study 35751090 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK (group PE; N=20)
Number of subjects: 60
Study 35751090 — intervention group
Group type: EXPERIMENTAL
Intervention: PEKK (group PK; N=20)
Number of subjects: 60
Study 33882949 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerobotic assistance during locomotion
Number of subjects: 6
Study 32755889 — intervention group
Group type: EXPERIMENTAL
Intervention: TRavelVU Plus app
Number of subjects: 17
Study 34514706 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-Focused Support Program (SFSP), 4 sessions of online support, 1 session per week
Number of subjects: 77
Study 34514706 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 77
Study 32169003 — intervention group
Group type: EXPERIMENTAL
Intervention: Support group for typically developing siblings; details on dosage and duration not available.
Number of subjects: 0
Study 32169003 — intervention group
Group type: COMPARATOR
Intervention: Similar group without a focus on the sibling with autism spectrum disorder; details on dosage and duration not available.
Number of subjects: 0
Study 32116139 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial food coloring (AFC) 225 mg in chocolate cookies for 3 days
Number of subjects: 29
Study 32116139 — intervention group
Group type: COMPARATOR
Intervention: Placebo chocolate cookies for 3 days
Number of subjects: 29
Study 33964196 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural solution of bupivacaine 1 mg mL-1, fentanyl 2 μg mL-1 with adrenaline 2 μg mL-1
Number of subjects: 36
Study 33964196 — intervention group
Group type: COMPARATOR
Intervention: Epidural solution of bupivacaine 1 mg mL-1, fentanyl 2 μg mL-1 without adrenaline
Number of subjects: 36
Study 34292210 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic liver surgery (LLS)
Number of subjects: 36
Study 34292210 — intervention group
Group type: COMPARATOR
Intervention: Open liver surgery (OLS)
Number of subjects: 36
Study 34292210 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LLS and OLS
Number of subjects: 36
Study 32371558 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 0
Study 35225089 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive episodic future thinking
Number of subjects: 572
Study 35225089 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral episodic future thinking
Number of subjects: 572
Study 35225089 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative episodic future thinking
Number of subjects: 572
Study 32559809 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy (PM) for head and neck cancer (HNC)
Number of subjects: 44
Study 33508334 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous exercise
Number of subjects: 20
Study 33508334 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise
Number of subjects: 20
Study 33508334 — intervention group
Group type: COMPARATOR
Intervention: Seated rest condition
Number of subjects: 20
Study 33091360 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCBs)
Number of subjects: 758
Study 33091360 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stents (DESs)
Number of subjects: 758